Literature DB >> 7881548

Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain.

I Charles1, N Fairweather, D Pickard, J Beesley, R Anderson, G Dougan, M Roberts.   

Abstract

The mature pertactin protein (P.69) of Bordetella pertussis can be isolated from the bacterial cell surface as a polypeptide with an apparent molecular mass of 69,000 Da as determined by sodium dodecyl sulphate gel electrophoresis. However the open reading frame of prn, the pertactin gene, encodes a polypeptide with a predicted molecular mass of 93,478 Da, referred to as P.93. Expression of the prn gene in Escherichia coli leads to the synthesis of the full-length P.93 polypeptide, which is rapidly processed to the mature P.69 protein located at the cell surface. The P.93 precursor polypeptide is processed at both termini. A 34 amino acid long signal sequence is removed from the amino-terminus and a polypeptide sequence of about 30,000 Da (P.30) is cleaved from the carboxy-terminus. Deletion of the 3' region of prn, encoding P.30, results in the expression of an intracellular form of P.69. Antiserum which recognizes P.30 was raised using synthetic peptides based on the primary amino acid sequence of the region. This anti-P.30 serum was used in a Western blot analysis of fractionated cells of B. pertussis and E. coli harbouring the intact prn gene. The P.30 polypeptide was readily detected in outer membrane fractions prepared from both of these bacterial species, although it could not be shown to be exposed at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7881548     DOI: 10.1099/13500872-140-12-3301

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  11 in total

1.  The C-terminal domain of the Bordetella pertussis autotransporter BrkA forms a pore in lipid bilayer membranes.

Authors:  J L Shannon; R C Fernandez
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

Review 2.  Virulence functions of autotransporter proteins.

Authors:  I R Henderson; J P Nataro
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Characterization of the essential transport function of the AIDA-I autotransporter and evidence supporting structural predictions.

Authors:  J Maurer; J Jose; T F Meyer
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

Review 4.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 5.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Type V Secretion: the Autotransporter and Two-Partner Secretion Pathways.

Authors:  Harris D Bernstein
Journal:  EcoSal Plus       Date:  2010-09

8.  Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.

Authors:  Marcel Hijnen; Frits R Mooi; Pieter G M van Gageldonk; Peter Hoogerhout; Audrey J King; Guy A M Berbers
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Cleavage of a bacterial autotransporter by an evolutionarily convergent autocatalytic mechanism.

Authors:  Nathalie Dautin; Travis J Barnard; D Eric Anderson; Harris D Bernstein
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

10.  Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.

Authors:  Wasin Buasri; Attawut Impoolsup; Chuenchit Boonchird; Anocha Luengchaichawange; Pannipa Prompiboon; Jean Petre; Watanalai Panbangred
Journal:  BMC Microbiol       Date:  2012-04-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.